Great Diamond Partners
ABBV icon

Great Diamond Partners’s AbbVie ABBV Stock Holding History

Great Diamond Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.36M Sell
5,204
-164
-3% -$42K 0.23% 104
2026
Q2 		$1.35M Sell
5,368
-5,459
-50% -$1.17M 0.23% 102
2026
Q1 		$2.35M Buy
10,827
+892
+9% +$198K 0.45% 71
2025
Q4 		$2.27M Buy
9,935
+118
+1% +$26.9K 0.44% 71
2025
Q3 		$2.27M Buy
9,817
+178
+2% +$36.2K 0.44% 70
2025
Q2 		$1.79M Buy
9,639
+1,040
+12% +$193K 0.38% 75
2025
Q1 		$1.8M Sell
8,599
-60
-0.7% -$11.7K 0.49% 63
2024
Q4 		$1.54M Buy
8,659
+207
+2% +$38.1K 0.4% 70
2024
Q3 		$1.67M Sell
8,452
-1,712
-17% -$320K 0.42% 69
2024
Q2 		$1.74M Sell
10,164
-666
-6% -$110K 0.41% 69
2024
Q1 		$1.97M Buy
10,830
+1
+0% +$172 0.45% 62
2023
Q4 		$1.68M Buy
10,829
+204
+2% +$29.7K 0.41% 63
2023
Q3 		$1.58M Buy
10,625
+171
+2% +$25.1K 0.43% 61
2023
Q2 		$1.41M Sell
10,454
-482
-4% -$70.7K 0.37% 73
2023
Q1 		$1.74M Sell
10,936
-888
-8% -$136K 0.5% 50
2022
Q4 		$1.91M Buy
11,824
+304
+3% +$46.6K 0.59% 47
2022
Q3 		$1.55M Buy
11,520
+3,998
+53% +$574K 0.53% 51
2022
Q2 		$1.15M Buy
7,522
+123
+2% +$18.8K 0.38% 62
2022
Q1 		$1.2M Buy
7,399
+31
+0.4% +$4.5K 0.33% 74
2021
Q4 		$997K Buy
7,368
+641
+10% +$75.7K 0.26% 88
2021
Q3 		$725K Buy
6,727
+2,134
+46% +$244K 0.2% 99
2021
Q2 		$517K Sell
4,593
-21
-0.5% -$2.36K 0.15% 117
2021
Q1 		$499K Buy
4,614
+21
+0.5% +$2.25K 0.15% 116
2020
Q4 		$492K Sell
4,593
-50
-1% -$4.8K 0.16% 106
2020
Q3 		$406K Buy
4,643
+28
+0.6% +$2.64K 0.15% 106
2020
Q2 		$453K Buy
4,615
+22
+0.5% +$1.94K 0.19% 85
2020
Q1 		$349K Hold
4,593
– – 0.18% 83
2019
Q4 		$406K Buy
+4,593
New +$381K 0.15% 88

Other funds holding ABBV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Great Diamond Partners's ABBV Position: Q3 2026 in Review

Great Diamond Partners reduced its AbbVie (ABBV) stake by 3.1% in Q3 2026, selling an estimated $42K and leaving 5,204 shares worth $1.36M. The position accounts for 0.23% of the portfolio, ranked #104.

Great Diamond Partners first reported a position in ABBV in Q4 2019 and has held it in 28 quarters since. The position peaked at $2.35M in Q1 2026. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Great Diamond Partners held 5,204 shares of AbbVie worth $1.36M as of Q3 2026.
  • Great Diamond Partners sold 164 AbbVie shares in Q3 2026, an estimated $42K.
  • AbbVie made up 0.23% of Great Diamond Partners's portfolio in Q3 2026, its #104 holding.
  • Great Diamond Partners first reported a position in AbbVie in Q4 2019 and has held it in 28 quarters since.
  • Great Diamond Partners's AbbVie position peaked at $2.35M in Q1 2026.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Great Diamond Partners's 13F filing for Q3 2026, filed 13 Oct 2026.